PrEP: latest news

PrEP resources

PrEP features

PrEP news from aidsmap

More news

PrEP news selected from other sources

  • PrEP for a new era

    It was an exciting morning for pre-exposure prophylaxis (PrEP) using daily oral TDF/FTC (brand-name Truvada).

    29 October 2014 | What's Up HIV (blog)
  • San Francisco to spend $300K improving access to PrEP

    The Board of Supervisors approved spending $300,000 Tuesday to fund so-called navigators to help residents gain access to an HIV-prevention drug, PrEP. The funding will be used to hire people in nonprofits to help residents learn about the drug, which can reduce users' chances of being infected, and to help them use their existing benefits like Medi-Cal to cover the drug expenses.

    29 October 2014 | San Francisco Examiner
  • Dr. Robert Grant, MD, MPH: The City of Love Could Lead the Way Toward Ending HIV Transmission

    As we enter our fourth decade without a cure for HIV, public interest in ending new infections has seemed to wane. Now's not the time to stop talking about AIDS. With important new treatment and prevention tools in our arsenal, San Francisco - known as the City of Love - could be the first U.S. city to end HIV transmission.

    29 October 2014 | Huffington Post
  • PrEP Pops Up On Cruising Sites

    We are now seeing the emergence of profiles where guys self-identify as PrEP users on cruising sites and apps like Grindr and Squirt. Is this a signal that PrEP is now a part of gay men’s sex lives? I decided to check out one of these sites to see what was happening.

    22 October 2014 | Positive Lite
  • The Welcome Side Effect of PrEP

    A spike in relationships that bridge the so-called viral divide may be an unintended side effect of the use of PrEP for HIV prevention.

    14 October 2014 | The Advocate
  • The Pill Truvada Can Prevent HIV/AIDS, and for Some, That's a Problem

    Researchers estimate that PrEP is over 90 percent effective if taken as prescribed. The PrEP program also calls for screenings for HIV and sexually transmitted infections at three-month intervals. This addresses a challenge doctors have struggled with for years: keeping at-risk people in contact with medical care for regular testing and rapid treatment. But despite its promise, PrEP has generated significant controversy in the LGBT and public health communities.

    08 October 2014 | Newsweek
  • Magnetic Love and Making Healthy Babies - Carolina's story

    Carolina describes her use of pre-exposure prophylaxis in order to have a baby with her HIV-positive partner.

    02 October 2014 | My PrEP Experience (blog)
  • Would an HIV-preventing drug change your world?

    BBC World Service phone-in discussion on pre-exposure prophylaxis (PrEP). Contributors include Michael Weinstein (AIDS Healthcare Foundation), Helen Rees (Wits Reproductive Health and HIV Institute), Garry Brough (Terrence Higgins Trust), David Campos (San Francisco Board of Supervisors) and PrEP users.

    01 October 2014 | BBC World Have Your Say (audio)
  • NYC promotes acceptance of controversial HIV drug

    New York City's health department is advertising on gay hookup apps and lobbying doctors to promote wider use of a controversial anti-HIV pill that vastly cuts the risk of infection. But the therapy has stoked infighting among AIDS activists over promiscuity and safer sex practices.

    01 October 2014 | Newsday
  • Can this HIV drug help to end 30 years of blighted lives?

    Truvada is giving peace of mind to gay men in the US – it should be offered here on the NHS now.

    29 September 2014 | The Guardian
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.